FDA commissioner commits to review of abortion pill
Washington Examiner
By Gabrielle M. Etzel
The Food and Drug Administration will conduct a review of the abortion pill mifepristone following intense pressure from Sen. Josh Hawley (R-MO) and anti-abortion advocates to review updated safety information for medication abortions.
FDA Commissioner Marty Makary wrote in a letter to Hawley on Monday that he is “committed to conducting a review of mifepristone and working with professional career scientists at the agency who review this data.